Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 108.40
-1.60 (-1.45%)
At close: Jan 9, 2026
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.73 billion as of January 9, 2026. Its market cap has increased by 78.27% in one year.
Market Cap
1.73B
Enterprise Value
1.62B
Revenue
170.24M
Ranking
n/a
PE Ratio
31.64
Stock Price
108.40
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.73B, an increase of 786.49%. That is a compound annual growth rate of 12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.73B | 3.04% |
| Dec 30, 2025 | 1.68B | 64.05% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 291.07B |
| Novartis AG | 218.82B |
| Galderma Group AG | 39.22B |
| Lonza Group AG | 38.88B |
| Alcon | 31.29B |
| Sandoz Group AG | 26.08B |
| Straumann Holding AG | 15.98B |
| Sonova Holding AG | 12.61B |